Search Results - "Powderly JD 2nd"

First-in-human phase I open-label study of the anti-TIM-3 monoclonal antibody INCAGN02390 in patients with select advanced or metastatic solid tumors.

Authors: Gutierrez ME Tang SC Powderly JD 2nd et al.

Source: The oncologist [Oncologist] 2025 Jul 04; Vol. 30 (7).

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

First-in-human phase I open-label study of the LAG-3 antagonist antibody INCAGN02385 in patients with select advanced or metastatic solid tumors.

Authors: Powderly JD 2nd Gutierrez ME Balmanoukian AS et al.

Source: The oncologist [Oncologist] 2025 Jul 04; Vol. 30 (7).

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

The application of autologous cancer immunotherapies in the age of memory-NK cells.

Authors: Lizana-Vasquez GD Torres-Lugo M Dixon RB et al.

Source: Frontiers in immunology [Front Immunol] 2023 May 02; Vol. 14, pp. 1167666. Date of Electronic Publication: 2023 May 02 (Print Publication: 2023).

Publication Type: Journal Article; Review; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

First-in-Human Phase I Study of ABBV-085, an Antibody-Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors.

Authors: Demetri GD Luke JJ Hollebecque A et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Jul 01; Vol. 27 (13), pp. 3556-3566. Date of Electronic Publication: 2021 Apr 05.

Publication Type: Clinical Trial, Phase I; Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE